SCHEMBL8513868

SCHEMBL8513868

CCc1cccc(-c2n[nH]c(-c3ccccc3)n2)c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 7/20 0.53
NR1H3 Q13133 7/20 0.53
HPGDS O60760 1/20 0.49
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
HPGD P15428 2/20 0.47
MAPT P10636 2/20 0.47
ALDH1A1 P00352 2/20 0.47
ATAD2 Q6PL18 1/20 0.47
TSHR P16473 1/20 0.47
HTT P42858 1/20 0.47
LMNA P02545 2/20 0.46
DGAT1 O75907 1/20 0.46
ADORA2A P29274 3/20 0.44
CYP1A2 P05177 2/20 0.44
TP53 P04637 1/20 0.44
ALPL P05186 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27923089 0.83 NR1H2 (0.49) NR1H2NR1H3HPGDSNPC1RAB9A
SCHEMBL11171303 0.80 NR1H2 (0.60) NR1H2NR1H3HPGDSNPC1RAB9A
SCHEMBL27941786 0.78 NR1H2 (0.61) NR1H2NR1H3HPGDSNPC1RAB9A
SCHEMBL17280037 0.77 NR1H2 (0.50) NR1H2NR1H3HPGDSNPC1RAB9A
SCHEMBL6861713 0.76 NR1H2 (0.51) NR1H2NR1H3NPC1RAB9ASMN1; SMN2
SCHEMBL5678433 0.76 NR1H2 (0.64) NR1H2NR1H3ADORA2ACYP1A2CYP2C9
SCHEMBL607544 0.75 CD274 (0.71) KMT2APDCD1CD274
SCHEMBL28148107 0.74 NR1H2 (0.65) NR1H2NR1H3HPGDSNPC1RAB9A
SCHEMBL27923069 0.74 NR1H2 (0.51) NR1H2NR1H3HPGDSNPC1RAB9A
SCHEMBL17280023 0.71 NR1H2 (0.52) NR1H2NR1H3HPGDSNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120133273-A1 Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120133273-A1 Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device LAGE3, CRY1, CYBA NR1H2 2864/4885NR1H3 3012/4885HPGDS 3636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.